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P
40 is a lymphokine produced by activated CD4+ T cells
that was originally identified in the mouse as a 30--40
kDa factor capable of supporting the growth of certain T
helper clones (1), but not ofcytolyticT cell clones or offresh
T cells (2). Subsequently, mouse P40 was found to enhance
the growth of bone-marrow-derived mast cell lines in re-
sponse to IIr3 (3) and that of fetal thymocytes in response
to I1r2 (4) . Human P40 was shown to stimulate the prolifer-
ation of a megakaryoblastic leukemia (5), to cause increased
survival of certain T cell lines (6), and to enhance erythroid
burst forming activity (7, 8) . Considering these multiple ac-
tivities, it has been proposed that P40 be renamed Ilr9 (5) .
Recently, it has been shown that 11,2-dependent T cell
lines become tumorigenic after transfection with ID2cDNA
(9, 10), a clear demonstration that aberrant expression ofI1r2
can lead to T cell transformation . Herewe have followed the
same approach to examine the transforming potential of P40 .
Materials and Methods
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Summary
To test the transforming potential of deregulated P40/Interleukin 9 expression, we transfected
a mouse P40-dependent T cell line with P40 cDNA, and examined the tumorigenicity of the
resulting transfectants . When the cells, which grew autonomously in vitro, were injected
intraperitoneally or subcutaneously into syngeneic mice, a very high tumor incidence was observed
with as few as 10 4 cells per inoculum . Animals died as a result of widespread dissemination of
lymphomatous tissue to abdominal and thoracic organs . The same P40-dependent cell line transfected
with a control construct did not form tumors even after injection of 10' cells. These results
indicate that uncontrolled expression of P40 can support T cell proliferation in vivo, and may
be a transforming event involved in the development of certain T cell tumors.
Transfections .
￿
Mouse P40 cDNA P40.2B4 (11) was subcloned
into the Sal I site ofexpression vectorpBMGneo (12) . P40-dependent
T cell line TSl (1) was transfected by electroporation with the
resulting sense or antisense constructs. Transfectants were selected
in G418 and cloned by limiting dilution .
P40Assay.
￿
The concentration ofP40 secreted by transfectants
was determined by measuring the growth factor activity ofcondi-
tioned media for TS1 cells as described (1) . 1 U/ml is defined as
the concentration required for half-maximal growth . The specificity
of the TSI assay, which registers both P40 and IIJ4, was ensured
by inhibition with the IgG fraction of a rabbit antiserum raised
against purified P40 or with anti-11,4 mAb 1011 (13) .
Histology. Tissues were fixed in formalin and stained with
hematoxylin-eosin .
Results and Discussion
Expression ofP40 cDNA in P40-dependent T Cells.
￿
The
P40-dependent T cell line used in the present work was orig-
inally from a IAb-restricted KLH-specific Th clone by cul-
ture inmedium conditioned by PMA-stimulated Th cells (1) .
This cell line, TS1, is entirely dependent on an exogenous
source of either P40 or ID4 for its growth and survival in
vitro. TSl was transfected with a P40 cDNA cloned in ex-
pression vector pBMGneo in sense or missense orientation .
The cells transfected with the P40-expressing construct
(TS1.G6) no longer required exogenous P40 for growth (Fig.
1), whereas the cells transfected with the missense construct
(TS1.E10) remained factor-dependent . In the presence ofP40,
the two cell lines had essentially identical doubling tunes (11.6 h
and 12.3 h for TSLE10 and TS1.G6, respectively) . TSLG6
cells could be cloned in the absence of exogenous P40. How-
ever, addition of P40 increased the cloning efficiency about
two-fold, indicating that the cells were still responsive to the
factor.
TS1.G6-conditioned medium supported the growth of
normal TSl cells, and this activity was neutralized by the
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￿
Factor-independent growth ofTS1 cells transfected with P40
cDNA . TS1 cells transfected with P40 cDNA cloned in sense (TSLG6
cells) or missense (TSLE10) orientation in expression vector pBMGneo
were seeded in microwells at a density of 3000 cells/well, andgrown in
the presence (®) or absence (/) of P40 (5 U/ml) . Cell numbers were
evaluated after 3 d by measuring the hexosaminidase content ofthe wells.
IgG fraction ofa rabbit antiserum raised against purified P40
(Fig . 2) . The specificity of this inhibition was demonstrated
by the failure of the antiserum to block the proliferation of
TS1 cells induced by IIs4 . By reference to a dose-response
curve constructed with the recombinant factor, the amount
of P40 secreted by TS1.G6 cells was evaluated at N1 ng/106
cells/48 h . That this P40 originated from the transfected
cDNA and not from the endogenous gene was demonstrated
by the finding that the P40 message in TS1.G6 was larger
than normal P40 mRNA . This difference probably results
from the formation of a large transcript including the rabbit
(3 globin gene of the vector, as described for IL2 cDNA ex-
pressed from a similar construct (10) .
Taken collectively, these observations suggested that TS1.G6
cells functioned via an autocrine P40 loop. However, we failed
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Table 1.
￿
Tumorigenicity of TSI Cells Transfected with
P40 cDNA
TS1 transfectants were injected s.c . at the indicated doses into normal
or irradiated (600 rads) syngeneic C57BL/6 mice . TSLE10 andTSLG6
are the uncloned G418-resistant populations obtained after transfection
ofTS1with P40cDNA cloned in antisense and sense orientation, respec-
tively . TSLG6/n are individual clones isolated from the TSLG6 popula-
tion . Figures in parentheses correspond to mean survival times in days .
to block the proliferation of TSLG6 cells themselves with
our rabbit anti-P40 IgG fraction. This result is reminiscent
of the observations reported previously for factor-dependent
cell lines transfected with cDNA encoding GM-CSF (14),
ILA (15), or a nonsecreted form of IL3 targeted to the en-
doplasmic reticulum by addition of a KDEL motif (16) . It
suggests that endogenous P40 may bind to P40 receptors in-
tracellularly or reach local concentrations beyond the neu-
tralizing capacity o£ the antiserum .
Tumorigenicity ofP40-transfected T Cell Lines.
￿
Injection of
0,1 0 .3 1 .0 3 .0
Antibody Concentration (~1g/ml)
P40/Interleukin 9-Induced T Cell Tumorigenicity
Figure 2.
￿
Identification of P40 in medium condi-
tioned by TSLG6 cells. Factor-dependent TS1 cells were
grownwith P40 (5U/ml), IIA (50 U/ml), orTS1.G6-
conditioned medium (10%) in the presence of in-
creasing doses of rabbit anti-P40 IgG(0) or of anti-
11,4 mAb 11B11 (/) . The dotted line indicates the
background level observed in the absence of growth
factor.
Mice with
tumors/mice injected
Cells Size of inoculum Normal Irradiated
TS1.E10 107 0/5 0/5
TSLG6 10' 5/5 (81) 2/2 (46)
106 6/6 (93) 2/2 (70)
10, 5/5 (102) 2/2 (78)
10° 5/5 (116) 2/2 (101)
TS1.G6/2 106 5/5 (124) 2/2 (85)
TSLG6/3 106 5/5 (102) 2/2 (88)
TSLG6/5 106 4/5 (89) 2/2 (49)
TSLG6/6 106 5/5 (103) 2/2 (46)
TSLG6/102 106 5/5 (124) 2/2 (91)Figure 3 .
￿
Histology of lymph node infiltrated with TSLG6 cells. (A)
Area invaded by predominantly medium-sized neoplastic cells with some
large blasts (arrow) . (B) Section showing a majority of large blastic cells
with deeply indented nuclei and occasional prominent Golgi apparatus
(arrow) . x 980 .
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syngeneic C57BL/6 mice with TSLG6 cells resulted in the
development of progressive tumors that killed the animals
in 3-4 mo. A 100% tumor incidence was observed with in-
ocula ranging from 104 to 107 cells (Table 1). In irradiated
animals, tumors appeared somewhat earlier than in normal
mice, suggesting that TSLG6 cells elicited a significant im-
mune response in the syngeneic host . In sharp contrast with
these results, not a single tumor developed in normal or ir-
radiated mice injected with up to 107 cells of the control
TSLE10 line.
The tumorigenicity ofTSLG6 cells was not due to a minor
subset of the transfected population because five out of five
transfected clones were tumorigenic. Moreover, the possibility
that tumors arising in mice injected withTSLG6 cells could
be formed by host cells in response to P40 was ruled out by
analysis ofT cell receptor gene rearrangements in the tumoral
tissue and by the finding that cells recovered from a TSLG6
tumor were G418-resistant (data not shown) .
Histological examination ofthe mice injected with TSLG6
cells showed the presence oflymphomatous tissue infiltrating
not only lymph nodes but also abdominal and thoracic organs,
including lungs and thymus. In the lymph nodes, the neo-
plastic cells invade the pulp around the sinuses leaving only
a few residual islands of small lymphocytes . In some areas,
the tumor cells are predominantly ofmedium size with oc-
casional large blasts (Fig. 3 A), whereas, in other areas, all
cells are large and blastic with indented or lobulated nuclei
(Fig . 3 B) . The same differences are observed within clonal
TS1.G6 cultures and are characteristic of the TS1 cell line itself .
Conclusion .
￿
Our results show that P40 can act as a T cell
growth factor in vivo . Similar results have been obtained be-
fore with IL -2 (9, 10) but not so far with 114 (15), possibly
because o£ the potent anti-tumor reaction elicited by I1A trans-
fectants in vivo (17,) . The observation that a P40-dependent
T cell line becomes tumorigenic after transfection with P40
cDNA suggests that inappropriate expression of the P40 gene
could be involved in the development ofT cell tumors . Analysis
of P40 expression in T cell neoplasia or in other hematopoi-
etic tumors will now be required to evaluate the importance
of this phenomenon .
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